These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31150628)

  • 41. Edaravone alleviates cisplatin-induced neurobehavioral deficits via modulation of oxidative stress and inflammatory mediators in the rat hippocampus.
    Jangra A; Kwatra M; Singh T; Pant R; Kushwah P; Ahmed S; Dwivedi D; Saroha B; Lahkar M
    Eur J Pharmacol; 2016 Nov; 791():51-61. PubMed ID: 27492363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
    Baumann MH; Wang X; Rothman RB
    Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.
    Liu J; Feng L; Ma D; Zhang M; Gu J; Wang S; Fu Q; Song Y; Lan Z; Qu R; Ma S
    Neurosci Lett; 2013 Aug; 549():63-8. PubMed ID: 23791853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
    Barakat W; Safwet N; El-Maraghy NN; Zakaria MN
    Eur J Pharmacol; 2014 Feb; 724():43-50. PubMed ID: 24378346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
    Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
    J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of 2,2'-dithienyl diselenide on kainic acid-induced neurotoxicity in rat hippocampus.
    Bortolatto CF; Jesse CR; Wilhelm EA; Ribeiro LR; Rambo LM; Royes LF; Roman SS; Nogueira CW
    Neuroscience; 2011 Oct; 193():300-9. PubMed ID: 21820494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus.
    Al-Majed AA; Al-Omar FA; Nagi MN
    Eur J Pharmacol; 2006 Aug; 543(1-3):40-7. PubMed ID: 16828080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-lasting glutamatergic modulation induced by neonatal GABA enhancement in mice.
    Melamed O; Levav-Rabkin T; Zukerman C; Clarke G; Cryan JF; Dinan TG; Grossman Y; Golan HM
    Neuropharmacology; 2014 Apr; 79():616-25. PubMed ID: 24462620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
    Sil R; Ray D; Chakraborti AS
    Indian J Exp Biol; 2013 Feb; 51(2):129-38. PubMed ID: 23923606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus.
    Trabace L; Coluccia A; Gaetani S; Tattoli M; Cagiano R; Pietra C; Kendrick KM; Cuomo V
    Brain Res; 2000 May; 865(2):268-71. PubMed ID: 10821930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
    Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
    Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain.
    Brocardo PS; Assini F; Franco JL; Pandolfo P; Müller YM; Takahashi RN; Dafre AL; Rodrigues AL
    Toxicol Sci; 2007 May; 97(1):140-8. PubMed ID: 17327255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The influences of propofol on different kinds of brain injuries in rat brain slices].
    Yu BW; Xue QS; Xia M; Wang ZJ; Chen HZ
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1176-9. PubMed ID: 12921640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
    Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
    Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flaxseed oil as a neuroprotective agent on lead acetate-induced monoamineric alterations and neurotoxicity in rats.
    Abdel Moneim AE
    Biol Trace Elem Res; 2012 Sep; 148(3):363-70. PubMed ID: 22395955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arachidonic acid attenuates brain damage in a rat model of ischemia/reperfusion by inhibiting inflammatory response and oxidative stress.
    Qu Y; Zhang HL; Zhang XP; Jiang HL
    Hum Exp Toxicol; 2018 Feb; 37(2):135-141. PubMed ID: 29233001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabis exacerbates depressive symptoms in rat model induced by reserpine.
    Khadrawy YA; Sawie HG; Abdel-Salam OME; Hosny EN
    Behav Brain Res; 2017 May; 324():41-50. PubMed ID: 28212939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.